By Adriana Lee Benedict The 14th round of negotiations for the Trans-Pacific Partnership Agreement (TPPA, a multilateral trade agreement currently being negotiated by the USTR and 10 other countries) is currently underway in Leesburg, VA.…
So…it’s a bit late today, but each Friday we’ll be posting some highlights from the Yale Interdisciplinary Center for Bioethics newsletter (AKA “Frimail”), a really fantastic resource for those of us interested in what’s been going…
Al Roth has come across a troubling phenomenon in Australia, where medical internships are in short supply. Medical students languish in a critical condition The Australian Medical Students’ Association estimates almost 500 students will miss…
By Nicolas Terry Kathleen Boozang, The New Relators: In-House Counsel and Compliance Officers, SSRN David Asch & Kevin Volpp, What Business Are We In? The Emergence of Health as the Business of Health Care, NEJM…
By Katie Booth The FDA Law Blog has just published a semi-serious study by Kurt Karst on the growth of Title 21 of the United States Code (“USC”) compared to Title 21 of the Code of…
By: Scott Burris, JD Law has been used to protect and promote public health from the early days of European colonization of North America. Quarantine statutes and orders are reported from the mid-17th century. The…
By Holly Fernandez Lynch Nir Eyal’s post below has teed up the issue of doctors refusing to accept patients for reasons that seem to be pretty questionable. The latest example has to do with obesity,…
We got an email today announcing the Connected Health Symposium in Boston this October 25-26. Check out the agenda here. Elliott Fisher, Professor at The Dartmouth Institute and one of the architects of the concept…
We’ll occasionally be posting event announcements here, as well as calls for papers, etc. that are likely to be of interest to our readership. Speaking of which, one such announcement came in today (from Fritz Allhoff…
by Jonathan J. Darrow The expiration of the patent on $11-billion-per-year Lipitor® (atorvastatin calcium) last November received wide media attention and was eagerly greeted by consumers, reflecting public excitement that seems to have not yet…
